title: No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults.
authors.affiliation: *Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand †EAU08 University Paris Descartes and CIC1419 Inserm, Paris, France ‡Hopital Cochin, Assistance Publique-Hopitaux de Paris, Paris, France §Unite de Recherche clinique, AP-HP, Hopital Tarnier, Paris, France ‖Institut de Recherche pour le Développement (IRD) UMI 174-Program for HIV Prevention and Treatment (PHPT), Marseille, France ¶Lamphun Hospital, Lamphun, Thailand #Maha Sarakham Hospital, Maha Sarakham, Thailand **Hat Yai Hospital, Songkhla, Thailand ††Harvard School of Public Health, Boston, MA ‡‡Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
authors.forename: Wasna
authors.initials: W
authors.lastname: Sirirungsi
authors.forename: Saik
authors.initials: S
authors.lastname: Urien
authors.forename: Linda
authors.initials: L
authors.lastname: Harrison
authors.forename: Jiraporn
authors.initials: J
authors.lastname: Kamkon
authors.forename: Yardpiroon
authors.initials: Y
authors.lastname: Tawon
authors.forename: Nuananong
authors.initials: N
authors.lastname: Luekamlung
authors.forename: Suchart
authors.initials: S
authors.lastname: Thongpaen
authors.forename: Ampaipith
authors.initials: A
authors.lastname: Nilmanat
authors.forename: Gonzague
authors.initials: G
authors.lastname: Jourdain
authors.forename: Marc
authors.initials: M
authors.lastname: Lallemant
authors.forename: Sophie
authors.initials: S
authors.lastname: Le Coeur
authors.forename: Nicole
authors.initials: N
authors.lastname: Ngo-Giang-Huong
authors.forename: Andrew
authors.initials: A
authors.lastname: Owen
authors.forename: Tim R
authors.initials: TR
authors.lastname: Cressey
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000493:pharmacokinetics*; D015331:Cohort Studies; D005260:Female; D005838:Genotype; D005919:Glomerular Filtration Rate; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics*; D063065:Organophosphonates / Q000009:adverse effects / Q000493:pharmacokinetics*; D010949:Plasma / Q000737:chemistry*; D012189:Retrospective Studies; D000068698:Tenofovir
chemical_list: D000225:Adenine; D019380:Anti-HIV Agents; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D063065:Organophosphonates; D000068698:Tenofovir; C073492:ABCC4 protein, human